Edaravone Injection, Solution
Product Images NDC 66794-259

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Edaravone (NDC 66794-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

18 (Bag Label)

This text appears to be a description of Edaravone Injection, a medication used for intravenous infusion. Each 100 mL single-dose bag contains 30 mg of Edaravone along with inactive ingredients. The dosage details are provided in the enclosed package insert. It is important to administer the medication slowly over a period of 3 minutes and to discard unused IV solution. The medication should be used within 24 hours of opening the package and should not be added or mixed with other drugs. Storage instructions include keeping it between 20 to 25°C and away from children. The product is manufactured by Piramal Critical Care in Bethlehem, PA, USA.*

FDA Label Image

18 (Carton)

Description: NDC 6679125961 is an Edaravone Injection packaged in 30 mg/100 mL bags that should be infused over a 30-minute period. Each box includes 2 bags. It is a sterile solution for single-dose use. The unused portion should be discarded. The medication is meant for intravenous infusion. The formula consists of edaravone, sodium bisulfite, sodium chloride, and water for injection. This product is only for prescription use (Rx only).*

FDA Label Image

Edaravone-spl-structure (Edaravone Spl Structure)

FDA Label Image

14 (Graph)

This text shows data related to the change in ALS Functional Rating Scale - Revised (ALSFRS-R) at Week 24, comparing the effects of injection treatment versus placebo in terms of improvement or worsening. The data may also indicate the percentage of patents exhibiting specific changes.*

FDA Label Image

17 (Logo 2)

Piramal Critical Care*

FDA Label Image

17 (Logo)

This text says "Piramal Critical Care". Piramal Critical Care is a division of Piramal Enterprises Limited that specializes in providing critical care products and services for hospitals and healthcare facilities. Their products include intravenous anesthetics, pain management medications, and other critical care pharmaceuticals.*

FDA Label Image

18 (Pouch Label)

This text is a description of an Edaravone Injection, which is a medication containing 30 mg of active ingredient per 100 mL, with specific instructions for dosage, usage, storage, and cautions. It also includes information about inactive ingredients and manufacturer details. The text emphasizes not mixing this drug with other medications and provides details on proper storage conditions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.